EP1718302A4 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
EP1718302A4
EP1718302A4 EP05712759A EP05712759A EP1718302A4 EP 1718302 A4 EP1718302 A4 EP 1718302A4 EP 05712759 A EP05712759 A EP 05712759A EP 05712759 A EP05712759 A EP 05712759A EP 1718302 A4 EP1718302 A4 EP 1718302A4
Authority
EP
European Patent Office
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05712759A
Other languages
German (de)
French (fr)
Other versions
EP1718302A1 (en
Inventor
Anna Ottlecz
Rudolf Karl Andreas Giger
Carlos Alvarez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of EP1718302A1 publication Critical patent/EP1718302A1/en
Publication of EP1718302A4 publication Critical patent/EP1718302A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP05712759A 2004-01-30 2005-01-28 Organic compounds Withdrawn EP1718302A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0402100.2A GB0402100D0 (en) 2004-01-30 2004-01-30 Organic compounds
PCT/US2005/003427 WO2005074926A1 (en) 2004-01-30 2005-01-28 Organic compounds

Publications (2)

Publication Number Publication Date
EP1718302A1 EP1718302A1 (en) 2006-11-08
EP1718302A4 true EP1718302A4 (en) 2010-04-28

Family

ID=31971769

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05712759A Withdrawn EP1718302A4 (en) 2004-01-30 2005-01-28 Organic compounds

Country Status (3)

Country Link
EP (1) EP1718302A4 (en)
GB (1) GB0402100D0 (en)
WO (1) WO2005074926A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020006967A1 (en) * 1997-06-19 2002-01-17 Peter A. Campochiaro Methods of treatment of ocular neovascularization
EP1176141A1 (en) * 1999-03-05 2002-01-30 Suntory Limited HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE $g(a)4$g(b)2 RECEPTOR
WO2002039954A2 (en) * 2000-11-20 2002-05-23 Smithkline Beecham Corporation Novel compounds
WO2002067971A2 (en) * 2001-02-22 2002-09-06 Novartis Ag Use of endostatin in the treatment of ocular neovascularization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020006967A1 (en) * 1997-06-19 2002-01-17 Peter A. Campochiaro Methods of treatment of ocular neovascularization
EP1176141A1 (en) * 1999-03-05 2002-01-30 Suntory Limited HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE $g(a)4$g(b)2 RECEPTOR
WO2002039954A2 (en) * 2000-11-20 2002-05-23 Smithkline Beecham Corporation Novel compounds
WO2002067971A2 (en) * 2001-02-22 2002-09-06 Novartis Ag Use of endostatin in the treatment of ocular neovascularization

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2005074926A1 *

Also Published As

Publication number Publication date
WO2005074926A1 (en) 2005-08-18
EP1718302A1 (en) 2006-11-08
GB0402100D0 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
GB0410712D0 (en) Organic compounds
GB0409921D0 (en) Organic compounds
GB0413960D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0410264D0 (en) Organic compounds
GB0401089D0 (en) Organic compounds
GB0408066D0 (en) Organic compounds
GB0409235D0 (en) Organic compounds
GB0409602D0 (en) Organic compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060829

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RIN1 Information on inventor provided before grant (corrected)

Inventor name: OTTLECZ, ANNA

Inventor name: GIGER, RUDOLF, KARL, ANDREAS

Inventor name: ALVAREZ, CARLOS

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1100259

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20100329

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/4439 20060101AFI20100323BHEP

Ipc: A61P 27/02 20060101ALI20100323BHEP

17Q First examination report despatched

Effective date: 20110113

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120405

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1100259

Country of ref document: HK